comprehensive -WSS

comprehensive

author：focus 2025-10-01 23:59:20 - browse：8

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： What Mike Pence has said that could be used in a Donald Trump trial

hotspot

WSS

Telehealth for opioid use disorder is lifesaving

Will the IRA bring competition to the biologics market?

What Mike Pence has said that could be used in a Donald Trump trial

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

A cyberattack has disrupted hospitals and health care in several states

A cyberattack has disrupted hospitals and health care in several states

knowledge

comprehensive

hotspot

Cancer drug shortages should be causing more outrage

Biden calls for immediate release of Niger's president amid apparent coup

Supreme Court strikes down use of affirmative action

WATCH: Why do bright lights make us see spots?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Nearly two

United colonoscopy coverage change 'may cost lives,' doctors say

Regeneron agrees to White House price limits on anti

Alkermes shareholders re

Regeneron agrees to White House price limits on anti

entertainment

A common UTI test for kids haunts adults as a traumatic 'nightmare'

For BCIs, commercial hurdles may be bigger than scientific ones

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Microsoft strikes partnership with Duke Health to advance health AI

2 US Navy sailors arrested for allegedly spying for China

Walmart eyes Medicare Advantage provider ChenMed

focus

knowledge

Wikipedia

hotspot